STIM1 and prostate cancer: Genetic silencing of STIM1/Orai1 and STIM1/Orai3 protein complexes by siRNA interference has, for example, yielded promising reductions in tumour progression and metastasis in xenograft models of breast, cervical and prostate cancer [53,54].